Vitamins and Cancer

  • Alfred H. MerrillJr.
  • Ann T. Foltz
  • Donald B. McCormick
Part of the Human Nutrition book series (HUNU, volume 7)


The requirement of vitamins for growth and development, as well as their central role in carcinogen metabolism, has called the attention of many investigators toward their potential involvement in tumor induction and growth. Vitamins A, C, and E have been most associated with cancer (Committee on Diet, Nutrition, and Cancer, 1982), and the consumption of foods rich in these nutrients has been encouraged in public information brochures by major cancer organizations (e.g., the American Institute for Cancer Research and the American Cancer Society), and most recently, The Surgeon General’s Report on Nutrition and Health (Nutrition Policy Board, 1988) and Diet and Health (National Research Council, 1989).


Esophageal Cancer Lung Cancer Patient Serum Vitamin Polycythemia Vera Dietary Vitamin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S., and Suda, T., 1981, Differentiation of mouse myeloid leukemia cells induced by 1-alpha, 25-dihydroxyvitamin D3, Proc. Natl. Acad. Sci. USA 78: 4990–4994.CrossRefGoogle Scholar
  2. Ahmann, F. R., and Durie, B. G. M., 1984, Acute myelogenous leukemia modulation by B12 deficiency: A case with bone marrow blast cell assay corroboration, Br. J. Haematol. 58: 91–94.CrossRefGoogle Scholar
  3. Ajdokiewicz, A., and Pollit, N., 1976, Letter to the editor: Liver carcinoma and pyroxidine deficiency, Am. J. Clin. Nutr. 29 (8): 813.Google Scholar
  4. Aksoy, M., Basu, T. K., Brient, J., and Dickerson, J. W. T., 1980, Thiamin status of patients treated with drug combinations containing 5-flurouracil, Eur. J. Cancer 16: 1041–1045.Google Scholar
  5. Alberts, D., Peng, Y., and Moon, T., 1978, Alpha -tocopherol pretreatment increases adriamycin bone marrow toxicity, Biomedicine 29: 189–191.Google Scholar
  6. Alvi, N. K., Ahmad, S., and Hadi, S. M., 1984, Effect of riboflavin and light on the secondary structure of DNA, Chem. Biol. Interact. 48: 367–376.CrossRefGoogle Scholar
  7. Arvanitakis, C., Holmes, F. H., and Hearne, E., III, 1979, A possible association of pernicious anemia with neoplasia, Oncology 36: 127–129.CrossRefGoogle Scholar
  8. Atukorala, S., Basu, T., Dickerson, J., Donaldson, D., and Sakula, A., 1979, Vitamin A, zinc and lung cancer, Br. J. Cancer 40: 927–931.CrossRefGoogle Scholar
  9. Baker, H., Frank, O., Chen, T., Feingold, S., DeAngelis, B., and Baker, E. R., 1981, Elevated vitamin levels in colon adenocarcinoma as compared with metastatic liver adenocarcinoma from colon primary and normal adjacent tissue, Cancer 47: 2883–2886.CrossRefGoogle Scholar
  10. Band, P., Besner, J., Leclaire, R., Girard, C., Diorio, G., Deschamps, M., Gelinas, G., and Larochelle, D., 1982, Phase II study of 13-cis-retinoic acid toxicity, Cancer Treat. Rep. 66: 1759–1761.Google Scholar
  11. Barra, R., Randolph, V., Sumas, M. E., Lanighan, K., and Lea, M. A., 1982, Effects of nicotinamide, isonicotinamide and bleomycin on DNA synthesis and repair in rat heptaocytes and hepatoma cells, J. Natl. Cancer Inst. 69: 1353–1357.Google Scholar
  12. Basu, T. K., and Dickerson, J. W. T., 1976, The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas, Oncology 33: 250–252.CrossRefGoogle Scholar
  13. Basu, T. K., Dickerson, J. W. T., Raven, R. W., and Williams, D C, 1974, The thiamin status of patients with cancer as determined by the red cell transketolase activity, Int. J. Vit. Nutr. Res. 44: 53–58.Google Scholar
  14. Basu, T., Donaldson, D., Jenner, M., Williams, D., and Sakula, A., 1976, Plasma vitamin A in patients with bronchial carcinoma, Br. J. Cancer 33: 119–121.CrossRefGoogle Scholar
  15. Baugh, C. M., Krumdieck, C. L., and Nair, M. S., 1973, Polyglutamyl metabolites of methotrexate, Biochem. Biophys. Res. Commun. 52: 27–34.CrossRefGoogle Scholar
  16. Beard, M. F., Pitney, W. R., and Sanneman, E. H., 1954, Serum concentration of vitamin B12 in patients suffering from leukemia, Blood 9: 789–794.Google Scholar
  17. Bell, E., 1980, The excretion of a vitamin B6 metabolite and the probability of recurrence of early breast cancer, Eur. J. Cancer 16: 297–298.Google Scholar
  18. Bellog, W., and Ott, F., 1971, Therapy of actinic keratoses and basal cell carcinomas with local application of vitamin A acid, Cancer Chemother. Rep. 55: 59–60.Google Scholar
  19. Berger, N. A., Catino, D. M., and Vietti, T. J., 1982, Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro, Cancer Res. 42: 4382–4386.Google Scholar
  20. Bertram, J. S., Kolonel, L. N., and Meyskens, F. L., Jr., 1987, Rationale and strategies for chemoprevention of cancer in humans, Cancer Res. 47: 3012–3031.Google Scholar
  21. Bichler, A., Fuchs, D., Hausen, A., Hetzel, H., Konig, K., and Wachter, H., 1982, Urinary neopterine excretion in patients with genital cancer, Clin. Biochem. 15: 38–40.CrossRefGoogle Scholar
  22. Bidlack, W. R., Brown, R. C., and Mohan, C., 1986, Nutritional parameters that alter hepatic drug metabolism, conjugation, and toxicity, Fed. Proc. 45: 142–148.Google Scholar
  23. Birt, D. F., 1986, Update on the effects of vitamins A, C, and E and selenium on carcinogenesis, Proc. Soc. Exp. Biol. Med. 183: 311–320.CrossRefGoogle Scholar
  24. Bjelke, E., 1975, Dietary vitamin A and lung cancer, Int. J. Cancer 15: 561–565.CrossRefGoogle Scholar
  25. Blakeslee, J. R., Yamamoto, N., and Hinuma, Y., 1985, Human T-cell leukemia virus I induction by 5-iodo-2’deoxyuridine and N-methyl-N’-nitro-N-nitrosoguanidine: Inhibition by retinoids, L-ascorbic acid, and DLalpha-tocopherol, Cancer Res. 45: 3471–3476.Google Scholar
  26. Bleyer, W. A., 1978, The clinical pharmacology of methotrexate, Cancer 41: 36–51.CrossRefGoogle Scholar
  27. Block, G., and Sorenson, A., 1987, Vitamin C intake and dietary sources by demographic characteristics, Nutr. Cancer 10: 53–65.CrossRefGoogle Scholar
  28. Block, J., Chlebowski, R., and Dietrich, M., 1983, Potential for iapachol (NSC-11905) clinical trials reassessment with adjuvant quinone therapy, Med. Pediatr. Oncol. 11: 492A - 493A.Google Scholar
  29. Boing, H., Martinez, L., Frentzel-Beyme, R., and Oltersdorf, U., 1985, Regional nutritional pattern and cancer mortality in the Federal Republic of Germany, Nutr. Cancer 7: 121–130.CrossRefGoogle Scholar
  30. Bollag, W., 1974, Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice, Eur. J. Cancer 10: 731–737.Google Scholar
  31. Bollag, W., 1975, Prophylaxis of chemically-induced epithelial tumors with an aromatic retinoid acid analog, Eur. J. Cancer 11: 721–724.Google Scholar
  32. Bollag, W., and Matter, A., 1981, From vitamin A to retinoids in experimental and clinical oncology, Ann. NY Acad. Sci. 27: 9–23.CrossRefGoogle Scholar
  33. Bond, G. G., Thompson, F. E., and Cook, R. R., 1987, Dietary vitamin A and lung cancer: Results of a case—control study among chemical workers, Nutr. Cancer 9: 109–121.CrossRefGoogle Scholar
  34. Borek, C., Ong, A., Mason, H., Donahue, L., and Biaglow, J. E., 1986, Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms, Proc. Natl. Acad. Sci. USA 83: 1490–1494.CrossRefGoogle Scholar
  35. Bosl, G., Whitmore, W., Myers, W., and Goldbey, R., 1983, Phase II trial of 13-cis-retinoic acid in the treatment of patients with advanced germ cell tumors, Proc. Am. Assoc. Cancer Res. 24: 150.Google Scholar
  36. Brandes, D., Anton, E., Schofield, B., and Barnard, S., 1966, Role of lysosomal labilizers in treatment of mammary gland carcinomas with cyclophosphamide, Cancer Chemother. Rep. 50: 47–53.Google Scholar
  37. Bright-See, E., 1983, Vitamin C and cancer prevention, Semin. Oncol. 10: 294–298.Google Scholar
  38. Brock, K. E., Berry, G., Mock, P. A., MacLennan, R., Truswell, A. S., and Brinton, L. A., 1988, Nutrients in diet and plasma and risk of in situ cervical cancer, J. Natl. Cancer Inst. 80: 580–585.CrossRefGoogle Scholar
  39. Brown, R. R., Price, J. M., Friedell, G. H., and Burney, S. W., 1969, Tryptophan metabolism in patients with bladder cancer: Geographical differences, J. Natl. Cancer Inst. 53: 295–301.Google Scholar
  40. Bryan, G. T., 1986, The influence of niacin and nicotinamide on in vivo carcinogenesis, Adv. Exp. Med. Biol. 206: 331–338.Google Scholar
  41. Buamah, P. K., James, O. F., Skillen, A. W., and Harris, A. L., 1987, Serum vitamin B12 levels in patients with primary hepatocellular carcinoma during treatment with CB3717, J. Surg. Oncol. 34: 100–103.CrossRefGoogle Scholar
  42. Bulovskaia, L. N., 1976, Acetylation reaction in mice in the normal state and in tumors, Vopr. Onkol. 22: 59–63.Google Scholar
  43. Byar, D., and Blackard, C., 1977, Comparisons of placebo, pyridoxine, and topical thiothepa in preventing recurrence of stage 1 bladder cancer, Urology 10: 556–561.CrossRefGoogle Scholar
  44. Byers, T., Marshall, J., and Graham, S., 1986, Dietary vitamin A and cancer—A multisite case-control study, Nutr. Cancer 8: 107–116.CrossRefGoogle Scholar
  45. Byers, T. E., Graham, S., Haughey, B. P., Marshall, J. R., and Swanson, M. K., 1987, Diet and lung cancer risk: findings from the Western New York Diet Study, Am. J. Epidemiol. 125: 351–363.Google Scholar
  46. Cameron, E., and Campbell, A., 1974, The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic asid supplements in advanced human cancer, Chem. Biol. Interact. 9: 285–315.CrossRefGoogle Scholar
  47. Cameron, E., and Pauling, L., 1976, Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer, Proc. Natl. Acad. Sci. USA 73: 3685–3689.CrossRefGoogle Scholar
  48. Cameron, E., and Pauling, L., 1979a, Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer, Proc. Natl. Acad. Sci. USA 75: 4538–4542.CrossRefGoogle Scholar
  49. Cameron, E., and Pauling, L., 19796, Cancer and Vitamin C,Linus Pauling Institute of Science and Medicine, Menlow Park, CA.Google Scholar
  50. Capel, I., Leach, D., and Dowell, H., 1983, Vitamin E retards the lipoperoxidation resulting from anticancer drug administration, Cancer Res. 43: 59–62.Google Scholar
  51. Carmel, R., 1975, Extreme elevation of serum transcobalamin I in patients with metastatic cancer, N. Engl. J. Med. 292: 282–284.CrossRefGoogle Scholar
  52. Carmel, R., and Eisenberg, L., 1977, Serum vitamin B12 and transcobalamin abnormalities in patients with cancer, Cancer 40: 1348–1353.CrossRefGoogle Scholar
  53. Carpenter, M. P., 1986, Effects of vitamin E on the immune system, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 199–211.CrossRefGoogle Scholar
  54. Cassidy, J., Lippma, M., Lacroix, A., Peck, G., and Ozols, R., 1981, Phase II trial of 13-cis-retinoic acid in metastatic breast cancer and other malignancies, Proc. Am. Soc. Clin. Oncol. 23: 441.Google Scholar
  55. Chabner, B. A., DeVita, V. T., Livingston, D. M., and Oliverio, V. T., 1970, Abnormalities of tryptophan metabolism and plasma pyridoxal phosphate in Hodgkin’s disease, N. Engl. J. Med. 282: 838–843.CrossRefGoogle Scholar
  56. Chang, M-D., Friedman, F. K., Beychok, S., Shyong, J. S., and Osserman, E. F., 1981, Further studies of the riboflavin-binding immunoglobulin IgGgar. Resolution onto fractions of different riboflavin content and aspects of assembly, Biochemistry 20: 2916–2921.CrossRefGoogle Scholar
  57. Chester, J. F., Gaissert, H. A., Ross, J. S., Malt, R. A., and Weitzman, S. A., 1986, Augmentation of 1,2dimethylhydrazine-induced colon cancer by experimental colitis in mice: Role of dietary vitamin E, J. Natl. Cancer Inst. 76: 939–942.Google Scholar
  58. Chlebowski, R., Dietrich, M., Akman, S., and Block, J., 1983a, Vitamin K3 (menadione) inhibition of human tumor growth in the soft agar assay system, Proc. Am. Assoc. Cancer Res. 24: 563.Google Scholar
  59. Chlebowski, R., Block, J., Dietriich, M., Octay, E., Barth, N., Yanagihara, R., Gota, C., and Ali, I., 1983b, Inhibition of human tumor growth and DNA biosynthetic activity by vitamin K and warfarin in vitro and clinical results, Proc. Am. Assoc. Cancer Res. 24: 653.Google Scholar
  60. Choi, N. W., Miller, A. B., Fodor, J. G., Jain, M., Howe, G. R., Risch, H. A., and Ruder, A. M., 1987, Consumption of precursors of N-nitroso compounds and human gastric cancer, /ARC Sci. Publ. 1987 (84): 492–496.Google Scholar
  61. Chow, C., Chen, L., Thacker, R., and Griffith, R., 1984, Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoking, Environ. Res. 34: 8–17.CrossRefGoogle Scholar
  62. Chu, B. C. F., and Lawley, P. D., 1975, Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating reagents, Chem.—Biol. Interact. 10: 333–338.CrossRefGoogle Scholar
  63. Clamon, G. H., Feld, R., Evans, W. K., Weiner, R. S., Kramer, B. S., Lininger, L. L., Gardner, L. B., Wolfe, E. C., DeWys, W. D., and Hoffman, F. A., 1984, Serum folate and vitamin Bi2 levels in patients with small cell lung cancer, Cancer 53: 306–310.CrossRefGoogle Scholar
  64. Clopath, P., Smith, V. C., and McCully, K. S., 1975, Growth promotion by homocysteic acid, Science 192: 372–374.CrossRefGoogle Scholar
  65. Cohen, M., 1972, Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosurea by vitamin A and caffeine, J. Natl. Cancer Inst. 48: 927–932.Google Scholar
  66. Cohen, M., and Carbone, P. P., 1972, Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1nitrosourea and cyclophosphamide by Vitamin A, J. Natl. Cancer Inst. 48: 921–922.Google Scholar
  67. Cohen, M., Primack, A., Broder, L., and Williams, L., 1977, Vitamin A serum levels and dietary vitamin A intake in lung cancer patients, Cancer Lett. 4: 51–54.CrossRefGoogle Scholar
  68. Cohen, S., Wattenberg, J., and Bryan, G., 1976, Effect of avitaminosis A and hypervitaminosis A on urinary bladder carciongenicity of N4–5 nitro-2-furyl-2-thiazolyl formamide, Cancer Res. 36: 2334–2339.Google Scholar
  69. Colditz, G. A., Stampfer, M. J., and Willett, W. C., 1987, Diet and lung cancer. A review of the epidemiologic evidence in humans, Arch. Intern. Med. 147: 157–160.CrossRefGoogle Scholar
  70. Coleman, J., III, Walker, A., and Didolkar, M., 1983, Treatment of adriamycin-induced skin ulcers: A prospective controlled study, J. Surg. Oncol. 22: 129–135.CrossRefGoogle Scholar
  71. Colston, K., and Coombes, R., 1985, Characterization of 1,25 dihydroxyvitamin D3 receptors in rat breast tumor, in: Vitamin D: Chemical, Biochemical, and Clinical Update, Proceedings of the Sixth Workshop on Vitamin D, Merano, Italy, ( A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. V. Herrath, eds.), Walter de Gruyter, New York, p. 895.Google Scholar
  72. Colston, K., Colston, M., and Feldman, D., 1981, 1,25-Dihyroxyvitamin D3 and malignant melanoma, Endocrinology 108: 1083–86.Google Scholar
  73. Committee on Diet, Nutrition, and Cancer, National Academy of Sciences, 1982, Diet, Nutrition, and Cancer, National Academy Press, Washington, DC.Google Scholar
  74. Constantinides, P., and Harkey, M., 1985, Initiation of a transplantable fibrosarcoma by the synergism of two non-initiators, alpha-tocopherol and soya oil, Virchows Arch. 405: 285–297.CrossRefGoogle Scholar
  75. Cook, M., and McNamara, P., 1980, Effect of dietary vitamin Eon dimethylhydrazine-induced colonic tumors in mice, Cancer Res. 40: 1329–1331.Google Scholar
  76. Corrocher, R., DeSandre, G., Ambrosetti, A., Pachor, M. L., Bambara, L. M., and Hoffbrand, A. V., 1978, Specific and non-specific folate binding protein in normal and malignant human tissues, J. Clin. Pathol. 31: 659–665.CrossRefGoogle Scholar
  77. Creagan, E. T., Moertel, C. G., O’Fallon, J. R., Shutt, A. J., O’Connell, M. J., Rubin, J., and Frytak, S., 1979, Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer, N. Engl. J. Med. 301: 687–690.CrossRefGoogle Scholar
  78. Crepaldi, G., and Parpajola, A., 1964, Excretion of tryptophan metabolites in different forms of haemoblastosis, Clin. Chim. Acta 9: 106–117.CrossRefGoogle Scholar
  79. Daenen, S., Vellenga, E., van Dobbenburgh, O. A., and Halie, M. R., 1986, Retinoic acid as antileukemic therapy in a patient with acute promelocytic leukemia and Aspergillus pneumonia, Blood 67: 559–561.Google Scholar
  80. Davies, D., 1967, Effect of vitamin A on 7,12-dimethylbene(a)anthracene-induced papillomas in rhino mouse skin, Cancer Res. 27: 237–241.Google Scholar
  81. Dawson, E., Nosovitch, J., and Hannigan, E., 1984, Serum vitamin and selenium changes in cervical dysplasia, Fed. Proc. 43: 1914.Google Scholar
  82. Day, P. L., Payne, L. D., and Dinning, J. S., 1960, Procarcinogenic effect of vitamin B12 on p-dimethylaminofed rats, Proc. Soc. Exp. Biol. Med. 74: 854–857.Google Scholar
  83. DeLuca, H. F., and Ostrem, V., 1986, The relationship between the vitamin D system and cancer, Adv. Exp. Med. Biol. 206: 413–429.Google Scholar
  84. De Reuck, J. L., Sieben, G. J., Sieben-Praet, M. R., Ngendahayo, P., De Coster, J. P., and Vander Eecken, H. M., 1980, Wemicke’s encephalopathy in patients with tumors of the lymphoidc systems, Arch. Neurol. 37: 338–341.CrossRefGoogle Scholar
  85. DiSorbo, D. M., Paavola, L. G., and Litwack, G., 1982, Pyridoxine resistance in a rat hepatoma cell line, Cancer Res. 42: 2362–2370.Google Scholar
  86. DiSorbo, D. M., Wagner, R., Jr., and Nathanson, L., 1985, In vivo and in vitro inhibition of B16 melanoma growth by vitamin B6, Nutr. Cancer 7: 43–52.Google Scholar
  87. Dorr, R., and Alberts, D., 1983, Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse, Cancer Treat. Rep. 67: 499–501.Google Scholar
  88. Douglas, J. F., Huff, J., and Peters, A. C., 1984, No evidence of carcinogenicity of L-ascorbic acid (vitamin C) for rodents, J. Toxicol. Env. Health 14: 605–609.CrossRefGoogle Scholar
  89. Eichner, E. R., McDonald, C. R., and Dickson, B. A., 1978, Elevated serum levels of unsaturated folate binding protein: Clinical correlates in a general hospital population, Am. J. Clin. Nutr. 31: 1988–1992.Google Scholar
  90. Eisman, J., 1985, Regulation of human target cell response to 1,25 dihyroxyvitamin D3, in: Vitamin D: Chemical, Biochemical, and Clinical Update, Proceedings of the Sixth Workshop on Vitamin D, Merano, Italy, ( A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. V. Herrath, eds.), Walter de Gruyter, New York, pp. 879–886.Google Scholar
  91. Eisman, J., Maclntyre, I., Martin, T., and Frampton, R., 1980a, Normal and malignant breast tissue is a target organ for I,25(OH)2 vitamin D3, Clin. Endocrinol. 13: 267–272.CrossRefGoogle Scholar
  92. Eisman, J., Martin, T., Maclntyre, I., Frampton, R., Mosley, J., and Whitehead, R., 1980b, 1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line, Biochem. Biophys. Res. Commun. 93: 915.Google Scholar
  93. Englard, S., and Seifter, S., 1986, The biochemical functions of ascorbic acid, Annu. Rev. Nutr. 6: 365–406.CrossRefGoogle Scholar
  94. Enstrom, J. E., Kanim, L. E., and Breslow, L., 1986, The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California, Am. J. Public Health 76: 1124–1130.CrossRefGoogle Scholar
  95. Epstein, J., 1977, Chemicals and photocarcinogenesis, Aust. J. Dermatol. 18: 57–61.CrossRefGoogle Scholar
  96. Epstein, J., and Grenkin, D., 1981, Inhibition of ultraviolet-induced carcinogenesis by all-trans retinoic acid, J. Invest. Dermatol. 76: 178–180.CrossRefGoogle Scholar
  97. Epstein, S., Joshi, S., Andrea, J., Forsyth, J., and Mantel, N., 1967, The null effect of antioxidants on the carcinogenecity of 3,4,9,10-dibenzpyrene to mice, Life Sci. 6: 225–233.CrossRefGoogle Scholar
  98. Erbe, R. W., and Wang, J-C. C., 1984, Folate metabolism in humans, Am. J. Genet. 17: 277–287.CrossRefGoogle Scholar
  99. Eto, I., and Krumdieck, C. L., 1986, Role of vitamin B12 and folate deficiencies in carcinogenesis, Adv. Exp. Med. Biol. 206: 313–330.Google Scholar
  100. Evans, C., and Todd, I., 1969, Synkavite and radiotherapy in the treatment of bronchial carcinoma: A randomized trial, Clin. Radiol. 20: 228–230.CrossRefGoogle Scholar
  101. Farhangi, M., and Osserman, E. F., 1976, Myeloma with xanthoderma due to an IgG monoclonal anti-flavin antibody, N. Engl. J. Med. 294: 177–183.CrossRefGoogle Scholar
  102. Fiddler, W., Pensabene, J., Piotrowski, E., Philips, J., Keatining, J., Mergens, W., and Newmark, H., 1978, Inhibition of formation of volatile nitrosamines in fried bacon by the use of cure-solubilized alphatocopherol, J. Agric. Food Chem. 26: 653–56.CrossRefGoogle Scholar
  103. Fontana, J. A., Rogers, J. S., and Durham, J. P., 1986, The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia, Cancer 57: 209–217.CrossRefGoogle Scholar
  104. Foy, H., and Kondi, A., 1984, The vulnerable esophagus: Riboflavin deficiency and squamous cell dysplasia of the skin and the esophagus, J. Natl. Cancer Inst. 72: 941–948.Google Scholar
  105. Foy, H., and Mbaya, V., 1977, Riboflavin, Frog. Food Nutr. Sci. 2: 357–394.Google Scholar
  106. Foy, H., Kondi, A., Davies, J. N. P., Anderson, B., Parker, A., Preston, J., and Peers, F. J., 1974, Histologic changes in livers of pyridoxine-deprived baboons—Relation to alpha-fetoprotein and liver cancer in Africa, J. Natl. Cancer Inst. 53: 1295–1311.Google Scholar
  107. Frampton, R., Suva, L., Eisman, J., Findley, D., Moore, G., Moseley, J., and Martin, T., 1982, Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture, Cancer Res. 42: 1116–1119.Google Scholar
  108. Freake, H., Marocci, C., Iwasaki, J., and Maclntyre, I., 1981, 1,25-Dihydroxyvitamin D3 specifically binds to a human breast cancer cell line and stimulates growth, Biochem. Biophys. Res. Commun. 101: 113–1138.Google Scholar
  109. Fujimaki, I., 1926, Formation of carcinoma in albino rats fed on deficient diets, J. Cancer Res. 10: 469–477.Google Scholar
  110. Fujiyama, S., Morishita, T., Hashiguchi, O., and Sato, T., 1988, Plasma abnormal prothrombin (des-gammacarboxy prothrombin) as a marker of hepatocellular carcinoma, Cancer 61: 1621–16288.Google Scholar
  111. Fukushima, S., Shibata, M. A., Shirai, T., Tamano, S., and Ito, N., 1986, Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats, Cancer Res. 46: 1623–1626.Google Scholar
  112. Gailani, S. D., Holland, N. F., Nussbaum, A., and Olson, K. B., 1968, Chemical and biochemical studies of pyridoxine deficiency in patients with neoplastic diseases, Cancer 21: 975–988.CrossRefGoogle Scholar
  113. Garland, C., and Garland, F., 1980, Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9: 227–231.CrossRefGoogle Scholar
  114. Garland, C., Shekelle, R., Barrett-Connor, B., Criqui, M., Rossof, A., and Oglesby, P., 1985, Dietary vitamin D and calcium and risk of colorectal cancer, Lancet 1: 307–309.CrossRefGoogle Scholar
  115. Ghosh, J., and Das, S., 1985, Evaluation of vitamin A and C status in normal and malignant conditions and their possible role in cancer prevention, Jpn. J. Cancer Res. 76: 1174–1178.Google Scholar
  116. Ghoshal, A. K., and Farber, E., 1984, The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens, Carcinogenesis 5: 1367–1370.CrossRefGoogle Scholar
  117. Ghoshal, A. K., Ahluwalia, M., and Farber, E., 1983, The rapid induction of liver cell death in rats fed a choline-deficient methionine low diet, Am. J. Pathol. 113: 309–314.Google Scholar
  118. Giambarresi, L. I., Katyal, S. L., and Lambardi, B., 1982, Promotion of liver carcinogenesis in the rat by a choline-devoid diet: Role of liver cell necrosis and regeneration, Br. J. Cancer 46: 825–829.CrossRefGoogle Scholar
  119. Gold, E., Mertelsmann, R., Itri, L., Gee, T., Arlen, Z., Kemplin, S., Clarkson, B., and Moore, M., 1983, Phase I clinical trial of 13-cis-retinoic acid in myelodysplasitc syndromes, Cancer Treat. Rep. 67: 981–986.Google Scholar
  120. Gold, J., 1986, In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals, Cancer Treat. Rep. 70: 1433–1435.Google Scholar
  121. Goodman, G., Alberts, D., Ernst, D., and Meyskens, F., Jr., 1983, Phase I trial of retinol in cancer patients, J. Clin. Oncol. 1: 394–399.Google Scholar
  122. Goodwin, T. W., 1986, Metabolism, nutrition, and function of carotenoids, Annu. Rev. Nutr. 6: 273–297.CrossRefGoogle Scholar
  123. Gouveia, J., Mathew, G., Hergend, T., Gros, F., Lemaigre, G., and Santelli, G., 1982, Degree of bronchial metaplasia in heavy smokers and its regression after treatment with retinoid, Lancet 2: 710–712.CrossRefGoogle Scholar
  124. Grassetti, D. R., 1986, The antimetastatic and tumor growth retarding effects of sulfur containing analogs of nicotinamide, Cancer Lett. 31: 187–195.CrossRefGoogle Scholar
  125. Gregor, A., Lee, P., Roe, J., Wilson, M., and Melton, A., 1980, Comparison of dietary histories in lung cancer cases and controls with special reference to Vitamin A, Nutr. Cancer 2: 93–97.CrossRefGoogle Scholar
  126. Gregory, J. F., III, and Kirk, J. R., 1981, The bioavailability of vitamin B6 in foods, Nutr. Rev. 37: 1–8.Google Scholar
  127. Gridley, D. S., Stickney, D. R., Nutter, R. L., Slater, J. M., and Shultz, T. I., 1987, Suppression of tumor growth and enhancement of immune status with high levels of dietary vitamin B6 in BALB/c mice, J. Natl. Cancer Inst. 78: 951–959.Google Scholar
  128. Grosse, W., III, and Wade, A. E., 1971, The effects of thiamine consumption on liver microsomal drug-metabolizing pathways, J. Pharmacol. Exp. Ther. 176: 758–768.Google Scholar
  129. Ha, C., Kerkvilet, N. I., Miller, L. T., 1984, The effect of vitamin B6 dificiency on host susceptibility to Maloney sarcoma virus-induced tumor growth in mice, J. Nutr. 114: 938–945.Google Scholar
  130. Haber, S., and Wissler, R., 1962, Effect of vitamin E on carcinogenicity of methylcholanthrene, Proc. Soc. Exp. Biol. Med. 111: 774–775.CrossRefGoogle Scholar
  131. Haenszel, W., Correa, P., Lopez, A., Cuello, C., Zarama, G., and Fontham, E., 1985, Serum micronutrient levels in relation to gastric pathology, Int. J. Cancer 36: 43–48.CrossRefGoogle Scholar
  132. Hall, C. A., and Wanko, M., 1971, Increased transcobalamin I in a leukemoid reaction, J. Lab. Clin. Med. 78: 298–301.Google Scholar
  133. Halpern, R., Halpern, B. C., Stea, B., Dunlap, A., Conklin, K., Clark, B., Ashe, H., Sperling, L., Halpern, J. A., Hardy, D., and Smith, R. A., 1977, Pterin-6-aldehyde. A cancer cell catabolite: Identification and application in diagnosis and treatment of human cancer, Proc. Natl. Acad. Sci. USA 74: 587–591.CrossRefGoogle Scholar
  134. Hanck, A., 1986, Ascorbic acid and cancer, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 365–397.CrossRefGoogle Scholar
  135. Hanck, A. B., 1988, Vitamin C and cancer, Prog. Clin. Biol. Res. 259: 307–320.Google Scholar
  136. Hara, T., and Taniguchi, M., 1985, Relationship between the changes in properties and contents of riboflavin derivatives of NADPH—cytochrome P450 reductase in liver microsomes of riboflavin-deficient rats, J. Biochem. (Tokyo) 97: 473–482.Google Scholar
  137. Harada, T., Kitazawa, T., Maita, K., and Shirasu, Y., 1985, Effects of vitamin C on tumor induction by diethylnitrosamine in the respiratory tract of hamsters exposed to cigarette smoke, Cancer Lett. 25: 163–169.CrossRefGoogle Scholar
  138. Harmon, D., 1969, Dimethylbenzanthracene induced cancer: Inhibiting effect of dietary vitamin E, Clin. Res. 17: 125.Google Scholar
  139. Hausen, A., Fuchs, D., Grunewald, K., Huber, H., Konig, K., and Wachter, H., 1982, Urinary neopterine in the assessment of lymphoid and myeloid neoplasia and neopterine levels in haemolytic anemia and benign monoclonal gammopathy, Clin. Biochem. 15: 34–37.CrossRefGoogle Scholar
  140. Haussier, C. A., Marion, S. L., Pike, J. W., and Haussier, M. R., 1986, 1,25-Dihydroxyvitamin D3 inhibits the clonogenic growth of transformed cells via its receptor, Biochem. Biophys. Res. Commun. 139: 136–143.Google Scholar
  141. Haydey, R., Reed, M., Dzubow, L., and Shupack, J., 1980, Treatment of keratocanthomas with oral 13-cisretinoic acid, N. Engl. J. Med. 303: 560–562.CrossRefGoogle Scholar
  142. Heimburger, D. C.. Alexander, C. B., Birch, R., Butterworth, C. E., Jr., Bailey, W. C., and Krumdieck, C. L., 1988, Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial, JAMA 259: 1525–1530.Google Scholar
  143. Hellman, S., Ianotti, A. T., and Bertino, J. R., 1964, Determinations of the levels of serum folate in patients with carcinoma of the head and neck treated with methotrexate, Cancer Res. 24: 105–113.Google Scholar
  144. Helson, L., 1984, A trial of vitamin E in neuroectodermal tumors, Proc. Am. Soc. Clin. Oncol. 3: 80.Google Scholar
  145. Henderson, L. M., 1983, Niacin, Annu. Rev. Nutr. 3: 289–307.CrossRefGoogle Scholar
  146. Herbert, V., 1986, The role of vitamin B12 and folate in carcinogenesis, Adv. Exp. Med. Biol. 206: 293–311.Google Scholar
  147. Hill, D. L., and Grubbs, C. J., 1982, Retinoids as chemopreventive and anticancer agents in intact animals, Anticancer Res. 2: 111–124.Google Scholar
  148. Hinds, M., Kolonel, L., Rankin, J., and Lee, J., 1984, Dietary vitamin A, carotene, vitamin C, and risk of lung cancer in Hawaii, Am. J. Epidemiol. 119: 227–237.Google Scholar
  149. Hirano, H., Hamajima, S., Horiiuchi, S., Niitsu, Y., and Ono, S., 1983, Effects of B2-deficiency on lipoperoxide and its scavenging system in the rat lens, Int. J. Vit. Nutr. Res. 53: 377–382.Google Scholar
  150. Hirayama, T., 1979, Diet and cancer, Nutr. Cancer 1: 67–81.CrossRefGoogle Scholar
  151. Hoffman, F. A., 1985, Micronutrient requirements of cancer patients, Cancer 55: 295–300.CrossRefGoogle Scholar
  152. Hoogstraten, B., Baker, H., and Reizenstein, R., 1961, Correlation between serum folic acid activity and response to anti-folate therapy, Blood 18: 787.Google Scholar
  153. Hoover, K. L., Lynch, P. H., and Poirier, L. A., 1984, Profound postinitiation enhancement by short-term severe methionine, choline, vitamin B12, and folate deficiency of hepatocarcinogenesis in F344 rats given a single low-dose diethylnitrosamine injection, J. Natl. Cancer Inst. 73: 1327–1336.Google Scholar
  154. Horiuchi, S., and Ono, S., 1984, Effects of riboflavin administration on the phospholipid metabolism of rat liver impaired with carbon tetrachloride, Int. J. Vit. Nutr. Res. 54: 173–177.Google Scholar
  155. Horsman, M. R., Chaplin, D. J., and Brown, J. M., 1987, Radiosensitization by nicotinamide in vivo: A greater enhancement of tumor damage compared to that of normal tissues, Radiat. Res. 109: 479–489.CrossRefGoogle Scholar
  156. Horwitt, M., 1980, Therapeutic uses of vitamin E in medicine, Nutr. Rev. 38: 105–113.CrossRefGoogle Scholar
  157. Horwitt, M. K., 1986, The promotion of vitamin E, J. Nutr. 116: 1371–1377.Google Scholar
  158. Howard, W. B., and Willhite, C. C., 1986, Toxicity of retinoids in humans and animals, J. Toxicol.—Toxin Rev. 5: 55–94.CrossRefGoogle Scholar
  159. Hulshof, K. F., Gooskens, A. C., Wedel, M., and Bruning, P. F., 1987, Food intake in three groups of cancer patients. A prospective study during cancer treatment, Hum. Nutr. Appl. Nutr. 41: 23–37.Google Scholar
  160. Inculet, R. I., Norton, J. A., Nichoalds, G. E., Maher, M. M., White, D. E., and Brennan, M. F., 1987, Water-soluble vitamins in cancer patients on parenteral nutrition: A prospective study, J. Parenter. Enter. Nutr. 11: 243–249.CrossRefGoogle Scholar
  161. Ink, S. L., and Henderson, L. M., 1984, Vitamin B6 metabolism, Annu. Rev. Nutr. 4: 455–470.CrossRefGoogle Scholar
  162. Innis, W. S. A., McCormick, D. B., and Merrill, A. H., Jr., 1985, Variations in riboflavin binding by human plasma: Identification of immunoglobulins as the major proteins responsible, Biochem. Med. 34: 151–165.CrossRefGoogle Scholar
  163. Innis, W. S. A., Nixon, D. W., Murray, D. R., McCormick, D. B., and Merrill, A. H., Jr., 1986, Immunoglobulins associated with elevated riboflavin binding by plasma from cancer patients, Proc. Soc. Exp. Biol. Med. 181: 237–241.CrossRefGoogle Scholar
  164. Ip, C., 1982, Dietary vitamin E and mammary carcinogenesis in rats, Carcinogenesis 3: 1453–1456.Google Scholar
  165. Ip, C., 1988, Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection, Cancer Lett. 39: 239–246.CrossRefGoogle Scholar
  166. Israels, L., Walls, G., Ollmann, D., Friesen, E., and Israels, E., 1983, Vitamin K as a regulator of benzo(a)pyrene metabolism, mutagenesis, and carcinogenesis, J. Clin. Invest. 71: 1130–1140.CrossRefGoogle Scholar
  167. Ito, Y., 1981, Effect of an aromatic retinoic acid analog on growth of virus-induced papilloma and related neoplasias of rabbits, Eur. J. Cancer 17: 35–42.Google Scholar
  168. Jacobson, E. L., Smith, J. Y., Mingmuang, M., Meadows, R., Sims, J. L., and Jacobson, M. K., 1984, Effect of nicotinamide analogues on recovery from DNA damage in C3H10T1/2 cells, Cancer Res. 44: 2485–2492.Google Scholar
  169. Jacobson, M. K., Levi, V., Juarez-Salinas, H., Barton, R. A., and Jacobson, E. L., 1980, Effect of carcinogenic N-alkyl-N-nitroso compounds on nicotinamide adenine dinucleotide metabolism, Cancer Res. 40: 1797–1802.Google Scholar
  170. Jaffe, W., 1946, The influence of wheat germ oil on the production of tumors in rats by methylcholanthrene, Exp. Med. Surg. 4: 278–282.Google Scholar
  171. Kagan, Y. A., 1957, The effect of internal administration of riboflavine on the content of riboflavine in the urine of cancer patients, Patol. Fiziol. Eksp. Ter. 1: 44 48.Google Scholar
  172. Kagan, Y. A., 1960, Riboflavin determination in the urine of patients suffering from malignant neoplasms, Khirurgiya 2: 103–108.Google Scholar
  173. Kagerud, A., and Peterson, H., 1981, Tocopherol in tumor irradiation, Anticancer Res. 1: 35–38.Google Scholar
  174. Kagerud, A., Klintenberg, C., Lund, N., and Peterson, H., 1980, Influence of tocopherol on tumor cell oxygenation, Cancer Lett. 5: 185–9.CrossRefGoogle Scholar
  175. Kamiyama, S., Ohshima, H., Shimada, A., Saito, N., Bourgade, M. C., Ziegler, P., and Bartsch, H., 1987, Urinary excretion of N-nitrosamino acids and nitrate by inhabitants in high-and low-risk areas for stomach cancer in northern Japan, IARC Sci. Publ. 1987 (84): 497–502.Google Scholar
  176. Kaplan, H. S., and Rigler, L. G., 1945, Pernicious anemia and carcinoma of the stomach. Autopsy studies concerning their interrelationship, Am. J. Med. Sci. 209: 339–348.CrossRefGoogle Scholar
  177. Kaplan, I. I., 1944, One year observation of the treatment of cancer with avidin (egg white), Am. J. Med. Sci. 207: 733–743.CrossRefGoogle Scholar
  178. Kark, J., Smith, A., Sitzer, B., and Hames, C., 1981, Serum vitamin A and cancer incidence in Evans County, Georgia, J. Natl. Cancer Inst. 66: 7–16.Google Scholar
  179. Kato, T., Suzumura, Y., and Fukushima, M., 1988, Enhancement of blemoycin activity by 3-aminobenzamide, a poly (ADP-ribose) synthesis inhibitor, in vitro and in vivo, Anticancer Res. 8: 239–243.Google Scholar
  180. Katsouyanni, K., Willett, W., Trichopoulos, D., Boyle, P., Trichopoulou, A., Vasilaros, S., Papadiamantis, J., and MacMahon, B., 1988, Risk of breast cancer among Greek women in relation to nutrient intake, Cancer 61: 181–185.CrossRefGoogle Scholar
  181. Kaul, L., Heshmat, M. Y., Kovi, J., Jackson, M. A., Jackson, A. G., Jones, G. W., Edson, M., Enterline, J. P., Worrell, R. G., and Perry, S. L., 1987, The role of diet in prostate cancer, Nutr. Cancer 9: 123–128.CrossRefGoogle Scholar
  182. Kayden, H., Hatam, L., and Traber, M., 1984, Reduced tocopherol content of B cells from patients with chronic lymphocytic leukemia, Blood 63: 213–215.Google Scholar
  183. Kazarinoff, M. N., and McCormick, D. B., 1975, Rabbit liver pyridoxamine (pyridoxine) 5’-phosphate oxidase: Purification and properties, J. Biol. Chem. 250: 3436–3442.Google Scholar
  184. Kensler, C. J., Sugiura, K., Young, N. F., Halter, C. R., and Rhoads, C. P., 1941, Partial protection of rats by riboflavin with casein against liver cancer caused by dimethylaminobenzene, Science 93: 308–310.CrossRefGoogle Scholar
  185. Kiefer, C. R., McGuire, B. S., Osserman, E. F., and Garver, F. A., 1983, The modeled structure of the IgGGar VL region and its implications for anti-flavin and anti-DNP fine specificities, J. Immunol. 131: 1871–1875.Google Scholar
  186. King, M., and McCay, P., 1983, Modulation of tumor incidence and possible mechanism of inhibition of mammary carcinogenesis by dietary antioxidants, Cancer Res. 43: 2485–2490.Google Scholar
  187. Kinn, A-C., and Lantz, B., 1984, Vitamin B12 deficiency after irradiation for bladder carcinoma, J. Urol. 131: 888–890.Google Scholar
  188. Kirkemo, A. K., Burt, M. E., and Brennan, M. F., 1982, Serum vitamin level maintenance in cancer patients on total parenteral nutrition, Am. J. Clin. Nutr. 35: 1003–1009.Google Scholar
  189. Kjellen, E., Pero, R. W., Cameron, R., and Ranstam, J., 1986, Radiosensitizing effects of nicotinamide on a C3H mouse mammary adenocarcinoma. A study on per os drug administration, Acta Radio!. (Oncol.) 25: 281–284.CrossRefGoogle Scholar
  190. Kline, B. E., Rusch, H. P., Bauman, C. A., and Lavik, P. S., 1943, The effect of pyridoxine on tumor growth, Cancer Res. 3: 825–829.Google Scholar
  191. Kline, B. E., Miller, J. A., and Rusche, H. P., 1945, Certain effects of egg white and biotin on the carcinogenicity of p-dimethylaminoazobenzene in rats fed a sub-protective level of riboflavin, Cancer Res. 5: 641–643.Google Scholar
  192. Knekt, P., Aromaa, A., Maatela, J., Aaran, R. K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R., Saxen, E., and Teppo, L., 1988, Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up, Am. J. Epidemiol. 127: 28–41.Google Scholar
  193. Koch, H., 1978, Biochemical treatment of precancerous oral lesions: The effectiveness of various analogs of retinoic acid, J. Max-Fac. Surg. 6: 59–63.CrossRefGoogle Scholar
  194. Kokolis, N., and Ziegler, I., 1977, On the levels of phenylalanine, tyrosine, and tetrahydrobiopterin in the blood of tumor-bearing organisms, Cancer Biochem. Biophys. 2: 79–85.Google Scholar
  195. Kolonel, L. N., Hankin, J. H., and Yoshizawa, C. N., 1987, Vitamin A and prostate cancer in elderly men: Enhancement of risk, Cancer Res. 47: 2982–2985.Google Scholar
  196. Korpela, J., 1984, Avidin, a high affinity biotin-binding protein, as a tool and subject of biological research, Med. Biol. 62: 5–26.Google Scholar
  197. Korytnyk, W., 1979, Synthesis and biological activity of vitamin B6 analogs, Meth. Enzymol. 62: 454–483.CrossRefGoogle Scholar
  198. Kozik, A., and McCormick, D. B., 1984, Mechanism of pyridoxine uptake by isolated rat liver cells, Arch. Biochem. Biophys. 229: 187–193.CrossRefGoogle Scholar
  199. Krishnamurthi, S., Shanta, V., and Sastri, D., 1971, Combined therapy in bucal mucosal cancers, Radiology 99: 409–415.Google Scholar
  200. Kull, F. C., Jr., Brent, D. A., Parikh, I., and Cuatrecasas, P., 1987, Chemical identification of a tumor-derived angiogenic factor, Science 236: 843–845.CrossRefGoogle Scholar
  201. Kune, S., Kune, G. A., and Watson, L. F., 1987, Case—control study of dietary etiological factors: The Melbourne Colorectal Cancer Study, Nutr. Cancer 9: 21–42.CrossRefGoogle Scholar
  202. Kurl, R. N., and Villee, C. A., 1985, A metabolite of riboflavin binds to the 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD) receptor, Pharmacology 30: 241–244.CrossRefGoogle Scholar
  203. Kvale, G., Bjelke, E., and Gart, J., 1983, Dietary habits and lung cancer risk, Br. J. Cancer 31: 397–405.Google Scholar
  204. Kyle, R., and Jowsey, J., 1980, Effect of sodium fluoride, calcium carbonate and vitamin D on the skeleton in multiple myeloma, Cancer 45: 1669–1674.Google Scholar
  205. Ladner, H. A., and Holtz, F., 1979, Zum verhalten einiger B-vitamine nach strahlen und/oder zytostatikabehandlung gynakolischer karzinome, Strahlentherapie 75: 191–195.Google Scholar
  206. Ladner, H. A., and Salkeld, R. M., 1988, Vitamin B6 status in cancer patients: Effect of tumor site, irradiation, hormones and chemotherapy, Prog. Clin. Biol. Res. 259: 273–281.Google Scholar
  207. Lane, M., 1971, Induced riboflavin deficiency in treatment of patients with lymphomas and polycythemia vera, Proc. Am. Assoc. Cancer Res. 12: 85.Google Scholar
  208. Lawson, T., 1983, Nicotinamide stimulates the repair of carcinogen-induced DNA damage in the hamster pancreas in vitro, Anticancer Res. 3: 207–210.Google Scholar
  209. Lea, M. A., Barra, R., and Randolph, V., 1984, Effects of nicotinamide and structural analogs on DNA synthesis and cellular replication of rat hepatoma cells, Cancer Biochem. Biophys. 7: 195–202.Google Scholar
  210. Lee, C., and Chen, C., 1979, Enhancement of mammary tumorigenesis in rats by vitamin E deficiency, Proc. Am. Assoc. Cancer Res. 20: 132.Google Scholar
  211. Lenzen, S., Koppel, G., and Panten, U., 1985, Secretory, enzymatic, and morphological characterization of rat pancreatic endocrine tumours induced by streptozotocin and nicotinamide, Acta Endocrinol. 109: 361–368.Google Scholar
  212. Levij, I. S., and Pollack, M. B., 1968, Potentiating effect of vitamin A on 9–10 dimethyl, 1,2-benzathracenecarcinogenesis in the hamster cheek pouch, Cancer 22: 300–306.CrossRefGoogle Scholar
  213. Levine, N., and Meyskens, F., 1980, Topical vitamin-A-acid therapy for cutaneous metastatic melanoma, Lancet 2: 224–226.CrossRefGoogle Scholar
  214. Loescher, L., and Sauer, K., 1984, Vitamin therapy for advanced cancers, Oncol. Nurs. Forum 11: 38–45.Google Scholar
  215. Lombardi, B., and Shinozuka, H., 1979, Enhancement of 2-AAF liver carcinogenesis in rats fed a choline-deficient diet, Int. J. Cancer 23: 565–570.CrossRefGoogle Scholar
  216. London, R., Sundaram, G., and Schultz, M., 1981, Endocrine parameters and alpha-tocopherol therapy of patients with mammary dysplasia, Cancer Res. 41: 3811–3813.Google Scholar
  217. Lopez, S., and LeGardeur, B., 1982, Vitamin A, C, and E in relation to lung cancer incidence, Am. J. Clin. Nutr. 35: 851.Google Scholar
  218. Lopez, S., LeGarrdeur, B., and Johnson, W., 1981, Vitamin A status and lung cancer, Am. J. Clin. Nutr. 34: 641.Google Scholar
  219. Lu, S. H., Ohshima, H., Fu, H. M., Tian, Y., Li, F. M., Blettner, M., Wahrendorf, J., and Bartsch, H., 1986, Urinary excretion of N-nitrosoamino acids and nitrate by inhabitants of high-and low-risk areas for esophageal cancer in Northern China: Endogenous formation of nitrosoproline and its inhibition by vitamin C, Cancer Res. 46: 1485–1491.Google Scholar
  220. Ludgate, S. M., and Merrick, M. V., 1985, The pathogenesis of post-irradiation chronic diarrhea: Measurement of SeHCAT and B12 adsorption for differential diagnosis determines treatment, Clin. Radiol. 36: 275–278.CrossRefGoogle Scholar
  221. Lutzner, M., and Blanchet-Bardon, C., 1980, Oral retinoid treatment of human papillomavirus type 5 induced epidermodysplasia verruciformis, N. Engl. J. Med. 302: 1091.Google Scholar
  222. Lyon, J. L., Mahoney, A. W., West, D. W., Gardner, J. W., Smith, K. R., Sorenson, A. W., and Stanish, W., 1987, Energy intake: Its relationship to colon cancer risk, J. Natl. Cancer Inst. 78: 853–861.Google Scholar
  223. MacLennon, R., Dacosta, J., Day, N., Law, C., Ng, Y., and Shanmugarartnam, K., 1977, Risk factors for lung cancer in Singapore Chinese, Int. J. Cancer 20: 854–860.CrossRefGoogle Scholar
  224. Mahmoud, L., and Robinson, W., 1982, Vitamin A levels in human bladder cancer, Int. J. Cancer 30: 143–145.CrossRefGoogle Scholar
  225. Malick, M., Roy, R., and Sternberg, J., 1978, Effect of vitamin Eon post-irradiation death in mice, Experiential 34: 1216–1217.CrossRefGoogle Scholar
  226. Manolagas, S. C., 1987, Vitamin D and its relevance to cancer, Anticancer Res. 7: 625–638.Google Scholar
  227. Marcus, S. L., Dutcher, J. P., Paietta, E., Ciobanu, N., Strauman, J., Wiemik, P. H., Hutner, S. H., Frank, O., and Baker, H., 1987, Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells, Cancer Res. 47: 4208–4212.Google Scholar
  228. Marshall, J., Graham, S., and Mettlin, C., 1982, Diet in the epidemiology of oral cancer, Nutr. Cancer 3: 145–149.CrossRefGoogle Scholar
  229. Martin, T., Findlay, D., Maclntyre, I., Eisamn, J., Michelangeli, V., Moseley, J., and Partridge, N., 1980, Calcitonin receptors in a cloned human breast cancer cell line, Biochem. Biophys. Res. Commun. 96: 150–156.CrossRefGoogle Scholar
  230. Marubini, E., Decarli, A., Costa, A., Mazzoleni, C., Andreoli, C., Barbieri, A., Capitelli, E., Carlucci, M., Cavallo, F., Monferroni, N., Pastorino, U., and Salvini, S., 1988, The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer. Results of a case-control study, Cancer 61: 173–180.CrossRefGoogle Scholar
  231. McCay, P. B., 1985, Vitamin E: Interaction with free radicals and ascorbate, Annu. Rev. Nutr. 5: 323–340.CrossRefGoogle Scholar
  232. McCormick, D., Burns, F., and Albert, R., 1980, Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate, Cancer Res. 40: 1140–1143.Google Scholar
  233. McCormick, D. L., May, C. M., Thomas, C. F., and Detrisac, C. J., 1986, Anticarcinogenic and hepatotoxic interactions between retinyl acetate and butylated hydroxytoluene in rats, Cancer Res. 46: 5264–5269.Google Scholar
  234. Meister, N. T., and Thanassi, J. W., 1988, Vitamin B6 metabolism in McA-RH7777 cells, Cancer Res. 48: 1080–1085.Google Scholar
  235. Mendelson, R. W., Watkin, D. M., Horbett, A. P., and Fahey, J. L., 1958, Identification of the vitamin B12-binding protein in the serum of normals and of patients with chronic myelocytic leukemia, Blood 13: 740747.Google Scholar
  236. Menkes, M., and Comstock, J., 1984, Vitamins A and E and lung cancer, Am. J. Epidemiol. 120: 491.Google Scholar
  237. Menkes, M. S., Comstock, G. W., Vuilleumier, J. P., Helsing, K. J., Rider, A. A., and Brookmeyer, R., 1986, Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer, N. Engl. J. Med. 315: 1250–1254.CrossRefGoogle Scholar
  238. Mergens, W., Vane, F., Tannenbaum, S., Green, L., and Skipper, P., 1979, In vitro nitrosation of methapyrilene, J. Pharm. Sci. 68: 827–832.CrossRefGoogle Scholar
  239. Merrill, A. H., Jr., and Henderson, J. M., 1987, Diseases associated with defects in vitamin B6 metabolism or utilization, Annu. Rev. Nutr. 7: 137–156.CrossRefGoogle Scholar
  240. Merrill, A. H., Jr., and McCormick, D. B., 1980, Affinity chromatographic purification and properties of flavokinase (ATP:riboflavin 5 ’-phosphotransferase) from rat liver, J. Biol. Chem. 255: 1335–1338.Google Scholar
  241. Merrill, A. H., Jr., Lambeth, J. D., Edmondson, D. E., and McCormick, D. B., 1981, Formation and mode of action of flavoproteins, Annu. Rev. Nutr. 1: 281–317.CrossRefGoogle Scholar
  242. Mettlin, C., 1986, Changing the public’s health behaviors by diet and chemopreventive interventions, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 257–266.CrossRefGoogle Scholar
  243. Mettlin, C., and Graham, S., 1979, Dietary risk factors in human bladder cancer, Am. J. Epidemiol. 110: 255–263.Google Scholar
  244. Mettlin, C., Graham, S., and Swanson, M., 1979, Vitamin A and lung cancer, J. Natl. Cancer Inst. 62: 1435–1438.Google Scholar
  245. Meyer, L. M., Bertcher, R. W., Cronkite, E. P., Suarez, R. M., Miller, I. F., Mulzac, I. F., and Olivarreta, S. T., 1961, Co60 vitamin 1312 binding capacity of serum in persons with hematologic disorders, various medical diseases and neoplasms, Acta Med. Scand. 169: 557–575.CrossRefGoogle Scholar
  246. Meyskens, F. L., and Prasad, K. N. (eds.), 1986, Vitamins and Cancer, Humana Press, Clifton, NJ. Meyskens, Jr., F., Gilmartin, E., Alberts, D., Levine, N., Brooks, R., Daimon, S., and Surwit, E., 1982, Activity of isoretinoin against squamous cell cancers and preneoplastic lesions, Cancer Treat. Rep. 66: 1315–1319.Google Scholar
  247. Mickshe, M., Cemi, C., Kokron, O., Titscher, R., and Wrba, H., 1977, Stimulation of immune response in lung cancer patients by vitamin A therapy, Oncology 34: 234–238.CrossRefGoogle Scholar
  248. Mihich, E., and Nichol, C. A., 1959, The effect of pyridoxine deficiency on mouse sarcoma 180, Cancer Res. 19: 279–284.Google Scholar
  249. Mikol, Y. B., Hoover, K. L., Creasia, D., and Poirier, L. A., 1983, Hepatocarcinogenesis in rats fed methyl-deficient, amino acid-defined diets, Carcinogenesis 4: 1619–1629.CrossRefGoogle Scholar
  250. Miller, E. G., and Burns, H., Jr., 1984, N-Nitrosodimethylamine carcinogenesis in nicotinamide-deficient rats, Cancer Res. 44: 1478–1482.Google Scholar
  251. Miller, J. A., and Miller, E. C., 1953, The carcinogenic aminoazo dyes, Adv. Cancer Res. 1:339–396. Mills, E., 1983, The role of vitamin A in cancer, South Afr. Med. J. 63: 74–77.Google Scholar
  252. Mirvish, S. S., 1986, Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer, Cancer 58 (Suppl.): 1842–1850.CrossRefGoogle Scholar
  253. Mitchell, J., 1960, Clinical assessment of tetra-sodium 2-methyl-1,4-napthahydroquinone diphosphate as a radiosensitizer in the radiotherapy of malignant tumors, Br. J. Cancer 7: 140.Google Scholar
  254. Mitchell, J., Brinkley, D., and Haybrittle, J., 1965, Clinical trial of radiosensitizers, including synkavit and oxygen inhales at atmospheric pressure, Acta Radiol. Ther. Physiol. Biol. 3: 329–341.CrossRefGoogle Scholar
  255. Miyata, Y., Fukushima, S., Hirose, M., Masui, T., and Ito, N., 1985, Short-term screening of promoters of bladder carcionogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats, Jpn. J. Cancer Res. 76: 828–834.Google Scholar
  256. Miyaura, C., Abe, E., Koribayashi, T., Tanaka, H., Konno, K., Nishii, Y., and Suda, T., 1981, la,25Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells, Biochem. Biophys. Res. Comm. 102: 937–943.Google Scholar
  257. Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O’Connell, M. J., and Ames, M. M., 1985, High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy, N. Engl. J. Med. 312: 137–141.CrossRefGoogle Scholar
  258. Moon, R., Grubbs, C., Spron, M., and Goodman, D., 1977, Retinyl acetate inhibits mammary carcinogenesis induced by N-methyly-N-nitrosurea, Nature 267: 620–621.CrossRefGoogle Scholar
  259. Moon, R. C., McCormick, D. L., and Mehta, R. G., 1986a, Retinoids as chemotherapeutic agents: Alone and in combination, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 161–180.CrossRefGoogle Scholar
  260. Moon, T. E., Rodney, S., Peng, Y-M., Alberts, D. S., and Meyskens, F. L., Jr., 1986b, Design and compliance considerations of dietary intervention trials, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 267–282.CrossRefGoogle Scholar
  261. Morishige, F., Nakamura, T., Nakamura, N., and Morishige, N., 1986, The role of vitamin C in tumor therapy (human), in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 399–427.CrossRefGoogle Scholar
  262. Morris, H. P., 1941, Effect of pantothenic acid on growth of the spontaneous mammary carcinoma in female C3H mice, J. Natl. Cancer Inst. 2: 47–54.Google Scholar
  263. Morris, H. P., 1947, Effects on the genesis and growth of tumors associated with vitamin intake, Ann. NY Acad. Sci. 49: 119–140.CrossRefGoogle Scholar
  264. Munoz, N., Wahrendorf, J., Bang, L. J., Crespi, M., Thurnham, D. I., Day, N. E., Ji, Z. H., Grassii, A., Yan, L. W., Lin, L. G., Quan, L. Y., Yun, Z. C., Fang, Z. S., Yao, L. J., Correa, P., O’Conor, G. T., and Bosch, X., 1985, No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus, Lancet 2: 111–114.CrossRefGoogle Scholar
  265. Munoz, N., Hayashi, M., Bang, L. J., Wahrendorf, J., Crespi, M., and Bosch, F. X., 1988, Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: A randomized double-blind intervention study in China, J. Natl. Cancer Inst. 79: 687–691.Google Scholar
  266. Murer-Orlando, M. L., and Peterson, A. C., 1985, In situ nick translation of human and mouse chromosomes detected with a biotinylated nucleotide, Exp. Cell Res. 157: 322–334.Google Scholar
  267. Myers, C., McGuire, W., and Young, R., 1976, Adriamycin amelioration of toxicity by alpha tocopherol, Cancer Treat. Rep. 60: 961–962.Google Scholar
  268. Narisawa, T., Reddy, B., Wong, Q., and Weisburger, J., 1976, Effect of vitamin A deficiency on rat colon carcinogenesis, Cancer Res. 36: 1379–1383.Google Scholar
  269. National Research Council, 1989, Diet and Health. Implications for reducing chronic disease risk, Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences, National Research Council, National Academy Press, Washington D.C.Google Scholar
  270. Nduka, N., Skidmore, C. J., and Shall, S., 1980, The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase, Eur. J. Biochem. 105: 525–530.CrossRefGoogle Scholar
  271. Nettlesheim, P., 1980, Inhibition of carcinogenesis by retinoids, Can. Med. Assoc. J. 122: 757–765.Google Scholar
  272. Nettlesheim, P., and Williams, M., 1976, The influence of vitamin A on the susceptibility of rat lung to 3methylcholanthrene, Int. J. Cancer 17: 351–357.CrossRefGoogle Scholar
  273. Newberne, P. M., 1986, Lipotropic factors and oncogenesis, Adv. Exp. Med. Biol. 206: 223–251.Google Scholar
  274. Newberne, P., and Rogers, A., 1973, Rat colon carcinogenesis associated with aflatoxin and marginal vitamin A, J. Natl. Cancer Inst. 50: 439–448.Google Scholar
  275. Newberne, P. M., and Rogers, A. E., 1986, Labile methyl groups and the promotion of cancer, Annu. Rev. Nutr. 6: 407–432.CrossRefGoogle Scholar
  276. Newberne, P. M., and Suphakam, V., 1984, Influence of the antioxidants vitamins C and E and of selenium on cancer, in: Vitamins, Nutrition, and Cancer ( K. N. Prasad, ed.), Karger, Basel, pp. 46–67.Google Scholar
  277. Nexo, E., Olesen, H., Norredam, K., and Schwartz, M., 1975, A rare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma, Scand. J. Haematol. 14: 320–327.CrossRefGoogle Scholar
  278. Nichol, C. A., Smith, G. K., and Duch, D. S., 1985, Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin, Annu. Rev. Biochem. 54: 729–764.CrossRefGoogle Scholar
  279. Nomura, A., Stemmermann, G., Heilbrun, L., Salkeld, R., and Vuillemier, J., 1985, Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii, Cancer Res. 45: 2369–2372.Google Scholar
  280. Nutrition Policy Board, Department of Health and Human Services, 1988, The Surgeon General’s Report on Nutrition and Health, U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, DC, ( DHHA(PHS) Publication No. 88–50210.Google Scholar
  281. Nutter, L. M., Meisler, N. T., and Thanassi, J. W., 1983, Absence of pyridoxine-(pyridoxamine-) 5’-phosphate oxidase in Morris hepatoma 7777, Biochemistry 22: 1599–1604.CrossRefGoogle Scholar
  282. O’Connor, H. J., Habibzedah, N., Schorah, C. J., Axon, A. T., Riley, S. E., and Garner, R. C., 1985, Effect of increased intake of vitamin C on the mutagenic activity of gastric juice and intragastric concentrations of ascorbic acid, Carcinogenesis 6: 1675–1676.CrossRefGoogle Scholar
  283. Odukoya, O., Hawach, F., and Shklar, G., 1984, Retardation of experimental oral cancer by topical vitamin E, Nutr. Cancer 6: 98–104.CrossRefGoogle Scholar
  284. Ohno, Y., Yoshida, O., Oishi, K., Okada, K., Yamabe, H., and Schroeder, F. H., 1988, Dietary beta-carotene and cancer of the prostate: A case-control study in Kyoto, Japan, Cancer Res. 48: 1331–1336.Google Scholar
  285. Olson, J. A., 1987, Recommended dietary intakes (RDI) of vitamin A in humans, Am. J. Clin. Nutr. 45: 704–716.Google Scholar
  286. Olson, J. A., and Hodges, R. E., 1987, Recommended dietary intakes (RDI) of vitamin C in humans, Am. J. Clin. Nutr. 45: 693–703.Google Scholar
  287. Ong, D., and Chytil, F., 1983, Vitamin A and cancer, Vit. Horm. 40: 105–44.CrossRefGoogle Scholar
  288. Pacernick, L. J., Soltani, K., and Lorincz, A. L., 1975, The inefficacy of riboflavin against ultraviolet-induced carcinogenesis, J. Invest. Dermat. 65: 547–548.CrossRefGoogle Scholar
  289. Paganini-Hill, A., Chao, A., Ross, R. K., and Henderson, B. E., 1987, Vitamin A, beta-carotene, and the risk of cancer: A prospective study, J. Natl. Cancer Inst. 79: 443–448.Google Scholar
  290. Park, C. H., 1985, Biological nature of the effect of ascorbic acids on the growth of human leukemic cells, Cancer Res. 45: 3969–3973.Google Scholar
  291. Pascoe, G. A., Olafsdottir, K., and Reed, D. J., 1987, Vitamin E protection against chemical-induced cell injury. I. Maintenance of cellular protein thiols as a cytoprotective mechanism. Arch. Biochem. Biophys. 256: 150–158.Google Scholar
  292. Pastorino, U., Pisani, P., Berrino, F., Andreoli, C., Barbieri, A., Costa, A., Mazzoleni, C., Gramegna, G., and Marubini, E., 1987, Vitamin A and female lung cancer: A case—control study in plasma and diet, Nutr. Cancer 10: 171–179.CrossRefGoogle Scholar
  293. Patek, P., Collins, J., Yogeeswaran, G., and Dennert, G., 1979, Antitumor potential of retinoic acid, Int. J. Cancer 24: 624–628.CrossRefGoogle Scholar
  294. Pauling, L., and Moertel, C., 1986, A proposition: Megadoses of vitamin C are valuable in the treatment of cancer, Nutr. Rev. 44: 28–32.CrossRefGoogle Scholar
  295. Pauling, L., Willoughby, R., Reynolds, R., Blaisdell, B., and Lawson, S., 1982, Incidence of squamous cell carcinoma in hairless mice irradiated with ultraviolet light in relation to intake of ascorbin acid (vitamin C) and of D,L-alpha-tocopheryl acetate (vitamin E), Int. Z. vitam. Ernahrungsforsch. 23: 53–82.Google Scholar
  296. Pauling, L., Nixon, J. C., Stitt, F., Marcuson, R., Dunham, W. B., Barth, R., Bensch, K., Herman, Z. S., Blaisdell, B. E., Tsao, C., Prender, M., Andrews, V., Willoughby, R., and Zuckerkandl, E., 1985, Effect of dietary ascorbic acid on the incidence of spontaneous mammary tumors in RIII mice, Proc. Natl. Acad. Sci. USA 82: 5185–5189.CrossRefGoogle Scholar
  297. Paveic, Z., Dave, S., Bialkowski, S., Priore, R., and Greco, W., 1980, Antitumor activity of Cornynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma, Cancer Res. 40: 4617–4621.Google Scholar
  298. Peck, G., Olsen, T., Butkus, J., Pandya, M., Arnaud-Battandier, J., Yoder, F., and Lewis, W., 1979, Treatment of basal cell carcinomas with 13-cis-retinoic acid, Proc. Am. Assoc. Clin. Res. 20: 56.Google Scholar
  299. Pelej, I., Heyden, S., Knowles, M., and Hames, O., 1984, Serum retinol and risk of subsequent cancer; extension of the Evans Country, Georgia, study, J. Natl. Cancer Inst. 73: 1455–1488.Google Scholar
  300. Percheliet, J. P., Abney, N. L., Thomas, R. M., Guislain, Y. L., and Perchellet, E. M., 1987, Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin, Cancer Res. 47: 477–485.Google Scholar
  301. Pierson, H. F., Fisher, J. M., and Rabinovitz, M., 1985, Depletion of extracellular cysteine with hydroxocobalamin and ascorbate in experimental murine cancer chemotherapy, Cancer Res. 45: 4727–4731.Google Scholar
  302. Pinto, J., Huang, Y. P., Chaudhuri, R., and Rivlin, R. S., 1975, Riboflavin excretion and turnover in an unusual case of multiple myeloma, Clin. Res. 23: 426A.Google Scholar
  303. Polliack, A., and Sasson, Z., 1972, Enhancing effect of excess topical vitamin A on Rous sarcomas in chickens, J. Nad. Cancer Inst. 48: 407–416.Google Scholar
  304. Pologe, L. G., Goyal, A., and Greer, J., 1982, Nature of the riboflavin interaction with the immunoglobulin IgGgar: Analogue binding studies, Mol. Immunol. 19: 1499–1507.CrossRefGoogle Scholar
  305. Popov, A. I., 1987, Effect of the nonspecific prevention of thrombogenic complications on late results in the combined treatment of bladder cancer, Med. Radio!. (Mosk.) 32: 42–45.Google Scholar
  306. Potera, C., Rose, D. P., and Brown, R. R., 1977, Vitamin B6 deficiency in cancer patients, Am. J. Clin. Nutr. 30: 1677–1679.Google Scholar
  307. Potter, J. D., and McMichael, A. J., 1986, Diet and cancer of the colon and rectum: A case—control study, J. Natl. Cancer Inst. 76: 557–569.Google Scholar
  308. Prasad, K. N., 1984, Vitamins, Nutrition, and Cancer, Karger, Basel.Google Scholar
  309. Prasad, K. N., 1988, Mechanisms of action of vitamin E on mammalian tumor cells in culture, Prog. Clin. Biol. Res. 259: 363–375.Google Scholar
  310. Presant, C., and Bearman, R., 1981, Randomized study of 13-cis-retinoic acid plus buslufan (B) or B alone in chronic phase chronic granulocytic leukemia, Proc. Am. Soc. Clin. Oncol. 22: 448.Google Scholar
  311. Prior, F. G. R., 1985, Theoretical involvement of vitamin B6 in tumour initiation, Med. Hypotheses 16: 421–428.CrossRefGoogle Scholar
  312. Rachmilewitz, B., Rachmilewitz, M., Moshkowitz, B., and Gross, J. 1971, Serum transcobalamin in myeloid leukemia, J. Lab. Clin. Med. 78: 275–288.Google Scholar
  313. Rakieten, N., Gordon, B. S., Beaty, A., Cooney, D. A., Davis, R. D., and Schein, P. S., 1971, Pancreatic islet tumors produced by the combined action of streptozotocin and nicotinamide, Proc. Soc. Exp. Biol. Med. 137: 280–283.CrossRefGoogle Scholar
  314. Rama, B., and Prasad, K., 1983, Study on the specificity of alpha-tocopherol (vitamin E) acid succinate effects on melanoma, glioma, and neuroblastoma cells in culture, Proc. Soc. Exp. Biol. Med. 174: 302–307.CrossRefGoogle Scholar
  315. Rama Rao, P. B., Lagerlof, B., Einhorn, J., and Reizenstein, P. G., 1965, Folic acid activity in leukemia and cancer, Cancer Res. 23: 221–224.Google Scholar
  316. Rao, J. McBride, T., and Oleson, J., 1968, Recognition and evaluation of iapachol as an antitumor agent, Cancer Res. 28:1952–1954.Google Scholar
  317. Reynolds, R. D., 1986 Vitamin B6 deficiency and carcinogenesis, Adv. Exp. Med. Biol. 206: 339–347.Google Scholar
  318. Rivlin, R. S., 1975, Riboflavin and cancer, in: Riboflavin ( R. S. Rivlin, ed.), Plenum Press, New York, pp. 369–391.CrossRefGoogle Scholar
  319. Roberts, A., and Sporn, M., 1984, Cellular biology and biochemistry of the retinoids, in: The Retinoids, vol. 2 ( M. Sporn, A. Roberts, and D. Goodman, eds.), Academic Press, New York, pp. 209–286.Google Scholar
  320. Robson, L. C., and Schwarz, M. R., 1980, The effects of vitamin B6 deficiency on the lymphoid system and immune responses, in: Vitamin B6 Metabolism and Role in Growth ( G. P. Tryfiates, ed.), Food and Nutrition Press, Westport, CT, pp. 205–222.Google Scholar
  321. Rogers, A. E., 1975, Variable effects of a lipotrope-deficient, high-fat diet on chemical carcinogenesis in rats, Cancer Res. 35: 2469–2474.Google Scholar
  322. Rogers, A., Herndon, B., and Newberne, P., 1973, Induction by dimethylhydrazine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A, Cancer Res. 33: 1003–1009.Google Scholar
  323. Rokos, H., Rokos, K., Frisius, H., and Kirstaeder, H. J., 1980, Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthipterin, and pterin, Clin. Chim. Acta 105: 275–286.CrossRefGoogle Scholar
  324. Rose, D. P., and Sheff, M. D., 1967, Tryptophan metabolism in carcinoma of the breast, Lancet 1: 239–241.CrossRefGoogle Scholar
  325. Rosen, F., Mihich, E., and Nichol, E. E., 1964a, Selective metabolic and chemotherapeutic effects of vitamin B6 adntimetabolites, Vit. Horm. 22: 609–641.CrossRefGoogle Scholar
  326. Rosen, F., Satobayashi, H., and Nichol, C. A., 1964b, Different effects of folic acid deficiency and treatment with amethopterin on the growth of several rat tumors, Proc. Am. Assoc. Cancer Res. 5: 54.Google Scholar
  327. Rosenberg, M. R., Novicki, D. L., Jirtle, R. L., Novotny, A., and Michalopoulos, G., 1985, Promoting effect of nicotinamide on the development of renal tubular cell tumors in rats initiated with diethylnitrosamine, Cancer Res. 45: 809–814.Google Scholar
  328. Rosenberg, M. R., Strom, S. C., Pachman, S., Slotkin, T. A., and Michalopoulos, G., 1986, Induction of rat kidney ornithine decarboxylase by nicotinamide without a concomitant increase in DNA synthesis, Carcinogenesis 7: 175–178.CrossRefGoogle Scholar
  329. Rostock, R., Stryker, J., and Abt, A., 1980, Evaluation of high dose vitamin E as a radioprotective agent, Radiology 136: 763–766.Google Scholar
  330. Ruddell, W. S. J., Bone, E. S., Hill, M. J., and Waters, C. L., 1978, Pathogenesis of gastric cancer in pernicious anemia, Lancet 1: 521–523.CrossRefGoogle Scholar
  331. Russell, M. J., Thomas, B. S., and Bulbrook, R. D., 1988, A prospective study of the relationship between serum vitamins A and E and risk of breast cancer, Br. J. Cancer 57: 213–215.Google Scholar
  332. Saccomanno, G., Moran, P., Schmiidy, R., Hartshorn, D., Brian, D., Dreher, W., and Sowada, B., 1982, Effects of 13-cis-retiinoids on premalignant and malignant cells of lung origin, Acta Cytol. 26: 78–84.Google Scholar
  333. Saffiotti, U., Montesano, R., Sellakumar, A., and Borg, S., 1967, Experimental cancer of the lung, Cancer 20: 857–864.CrossRefGoogle Scholar
  334. Salonen, J., Salonen, R., Lappetelainen, R., Maenpaa, P., Alfthan, G., and Puska, P., 1985, Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case—control analysis of prospective data, Br. Med. J. 290: 417–420.CrossRefGoogle Scholar
  335. Samuels, L. L., Moccio, D. M., and Sirotnak, F. M., 1985, Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro, Cancer Res. 45: 1488–1485.Google Scholar
  336. Samuels, L. L., Goutas, L. J., Priest, D. G., Piper, J. R., and Sirotnak, F. M., 1986, Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse, Cancer Res. 46: 2230–2235.Google Scholar
  337. Sato, T., Takusagawa, K, and Konno, K., 1984, Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231, Br. J. Cancer 50: 123–125.CrossRefGoogle Scholar
  338. Schein, P. S., 1969, 1-Methyl-l-nitrosourea and dialkylnitrosamine depression of nicotinamide adenine dinucleotide, Cancer Res. 29: 1226–1232.Google Scholar
  339. Schmaehl, D., and Habs, M., 1978, Experiments on the influence of an aromatic retinoid on the chemical carcinogenesis in rats by butyl-butanol-nitrosamine and 1,2-dimethylhydrazine, Arzneim. Forsch. 28: 49–51.Google Scholar
  340. Schmitt-Graff, A., and Scheulen, M. E., 1986, Prevention of adriamycin cardiotoxicity by niacin, isocitrate or N-acetyl-cysteine in mice. A morphological study, Pathol. Res. Pract. 181: 168–174.CrossRefGoogle Scholar
  341. Schober, S. E., Comstock, G. W., Helsing, K. J., Salkeld, R. M., Morris, J. S., Rider, A. A., and Brookmeyer, R., 1987, Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk, Am. J. Epidemiol. 126: 1033–1041.Google Scholar
  342. Schrijver, J., Alexieva-Figusch, J., van Breederode, N., and van Gilse, H. A., 1987, Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen, Nutr. Cancer 10: 231–245.CrossRefGoogle Scholar
  343. Schroder, E., and Black, P., 1980, Retinoids: Tumor preventors or tumor enhancers? J. Natl. Cancer Inst. 65: 671–674.Google Scholar
  344. Sestili, M. A., 1983, Possible adverse health effects of vitamin C and ascorbic acid, Semin. Oncol. 10: 299–304.Google Scholar
  345. Shamberger, R. J., Nutrition and Cancer, Plenum Press, New York, 1984, Chapter 4.CrossRefGoogle Scholar
  346. Shamberger, R., Beaman, K., Corlett, C., and Kasten, B., 1978, Effect of selenium and other antioxidants on the mutagenicity of malonaldehyde, Fed. Proc. 37: 261.Google Scholar
  347. Shane, B., and Stokstad, E. L. R., 1985, Vitamin B12-folate interrelationships, Annu. Rev. Nutr. 5: 115–141.CrossRefGoogle Scholar
  348. Shapiro, D. M., Dietrich, L. S., and Shies, M. D., 1957, Quantitative biochemical differences between tumor and host as a basis of chemotherapy, Cancer Res. 17: 600–604.Google Scholar
  349. Shekelle, R., Lepper, M., Liu, S., Maliza, C., Raynor, W., Rossof, A., Paul, O., Shylock, A., and Stamler, J., 1981, Dietary vitamin A and risk of cancer in the Western Electric study, Lancet 2: 1186–90.Google Scholar
  350. Sheppard, K., Danbury, D. A., Davies, J. M., and Ryrie, D. R., 1984, Cobalamin and folate binding proteins inGoogle Scholar
  351. human tumour tissue, J. Clin. Pathol. 37:1336–1338.Google Scholar
  352. Shinozuka, H., and Lombardi, B., 1980, Synergistic effect of a choline-devoid diet and pheonbarbital in promoting the emergence of foci of gamma-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats, Cancer Res. 40: 3846–3849.Google Scholar
  353. Shirai, T., Ikawa, E., Hirose, M., Thamavit, W., and Ito, N., 1985a, Modification by five antioxidants of 1,2dimethylhydrazine-initiated colon carcinogenesis in F344 rats, Carcinogenesis 6: 637–639.CrossRefGoogle Scholar
  354. Shirai, T., Masuda, A., Fukushima, S., Hosoda, K., and Ito, N., 1985b, Effects of i_ ascorbate and related compounds on rat stomach carcinogenesis initiated by N-methyl-N’-nitro-N-nitroguanidine, Cancer Lett. 29: 283–288.CrossRefGoogle Scholar
  355. Shivapurkar, N., and Poirier, L. A., 1983, Tissue levels of S-adenosylmethionine and S-adenosylhornocysteine in rats fed methyl-deficient, amino acid-defined diets for one to five weeks, Carcinogenesis 4: 1051–1057.CrossRefGoogle Scholar
  356. Shklar, G., 1982, Oral mucosal carcinogenesis in hamsters: Inhibition by vitamin E, J. Natl. Cancer Inst. 68: 791–797.Google Scholar
  357. Shklar, G., Flynn, E., Szbo, G., and Marefat, P., 1980, Retinoid inhibition of experimental ligua) carcinogenesis, J. Natl. Cancer Inst. 65: 1307–1316.Google Scholar
  358. Shklar, G., Schwartz, J., Trickier, D. P., and Niukian, K., 1987, Regression by vitamin E of experimental oral cancer, J. Natl. Cancer Inst. 78: 987–992.Google Scholar
  359. Shoentel, R., 1977, The role of nicotinamide and other modifying factors in diethylnitrosamine carcinogenesis, Cancer 40: 1833–1840.CrossRefGoogle Scholar
  360. Sherman, M. L (ed.), 1986, Retinoids and Cell Differentiation, CRC Press, Boca Raton, FL.Google Scholar
  361. Siegel, B. V., and Morton, J. I., 1984, Vitamin C and immunity: Influence of ascorbate on prostaglandin Ez synthesis and implications for natural killer cell activity, lnt. J. Vit. Nutr. Res. 54: 339–342.Google Scholar
  362. Silverman, J., Katayama, S., Zelenkas, K., Lauber, J., Musser, T., Reddy, M., Levenstein, M.. and Weisburger, J., 1981, Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosurea or by 1,2 dimethylhydrazine, Carcinogenesis 2: 1167–1172.CrossRefGoogle Scholar
  363. Slaga, T., and Bracken, W., 1977, The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxlase, Cancer Res. 37: 1631–1635.Google Scholar
  364. Smith, D., Rogers, A., Herndon, B., and Nebeme, P., 1975a, Vitamin A and benzo(a)pyrene-induced respiratory tract carcinogenesis in hamsters fed a commercial diet, Cancer Res. 35: 11–16.Google Scholar
  365. Smith, D., Rogers, A., and Newbeme, P., 1975b, Vitamin A and benzo(a)pyrene carcinogenesis in the respiratory tract of hamsters fed a semisynthetic diet, Cancer Res. 35: 1485–1487.Google Scholar
  366. Sonneveld, P., 1978, Effect of alpha tocopherol on the cardiotoxicity of Adriamycin in the rat, Cancer Treat. Rep. 62: 1033–36.Google Scholar
  367. Sporn, M., and Newton, D., 1979, Chemoprevention of cancer with retinoids, Fed. Proc. 38: 2528–2534.Google Scholar
  368. Stahelin, H., Buess, E., Rosel, F., Widmer, L., and Brubacher, G., 1982, Vitamin A, cardiovascular risks, and mortality, Lancet 1: 394–395.CrossRefGoogle Scholar
  369. Stahelin, H. B., Rosel, F., Buess, E., and Brubacher, G., 1984, Cancer, vitamins, and plasma lipids: Prospective Basel study, J. Natl. Cancer Inst. 73: 1463–1468.Google Scholar
  370. Stahl, R. L., Farber, C. M., Liebes, L. F., and Silber, R., 1985, Relationship of dehydroascorbic acid transport to cell lineage in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia, Cancer Res. 45: 6507–6512.Google Scholar
  371. Stam, J., Germano, G., and Boorsma, M., 1982, Preliminary results of a 3 year double-blind study of the aromatic retinoid Tigason versus placebo as adjuvant therapy in patients who underwent a curative resection for epidermoid carcinoma of the lung, Eur. J. Respir. Dis. 63(Suppl. 125):Abstr. 100.Google Scholar
  372. Stea, B., Halpern, R. M., Halpern, B. C., and Smith, R. A., 1981, Urinary excretion of unconjugated pterins in cancer patients and normal individuals, Clin. Chim. Acta 113: 231–242.CrossRefGoogle Scholar
  373. Steen, P. H., Wallace, C. D., and Hoffman, R. M., 1984, Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines, J. Cell. Physiol. 119: 29–34.CrossRefGoogle Scholar
  374. Stehr, P., 1983, Vitamin A deficiencies as a predisposing factor in the development of stomach cancer, Diss. Abstr. Int. 43:2863-B.Google Scholar
  375. Stern, P. H., Wallace, C. D., and Hoffman, R. M., 1984, Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines, J. Cell. Physiol. 119: 29–34.CrossRefGoogle Scholar
  376. Stewart, D., Speer, R., Ridgeway, H., and Hill, J., 1979, Combination chemotherapy of leukemia L1210 with platinum compounds and vitamins, J. Clin. Hematol. Oncol. 9: 235–239.Google Scholar
  377. Stitch, H., Rosin, M., and Vallejera, M., 1984, Effect of vitamin A and Beta-carotene administration on the frequencies of micronucleated buccal mucosa cells of betel nut and tobacco chewers, Proc. Am. Assoc. Cancer Res. 25: 125.Google Scholar
  378. Su, Y. Z., Duarte, T. E., Dill, P. L., and Weisenthal, L. M., 1987, Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms, Cancer Treat. Rep. 71: 619–625.Google Scholar
  379. Surwit, E., Graham, V., Doregemueller, W., Alberts, D., Chvapil, M., Don, R., Davis, J., and Meyskens, Jr., F., 1982, Evaluation of topically applied trans-retinoic acid in the treatment of cervical intrepithelial lesions, Am. J. Obstet. Gynecol. 143: 821–823.Google Scholar
  380. Svingen, B., Powis, G., Appel, P., and Scott, M., 1981, Protection by alpha-tocopherol and dimethylsulfoxide (DMSO) against Adriamycin induced skin ulcers in the rat, Cancer Res. 41: 3395–3399.Google Scholar
  381. Taheri, M. R., Wickremasinghe, R. G., Jackson, B. F., and Hoffbrand, A. V., 1982, Effect of folate analogues and vitamin Bt2 on provision of thymine nucleotides for DNA synthesis in megaloblastic anemia, Blood 59: 634–640.Google Scholar
  382. Taper, H. S., de Gerlache, J., Lans, M., and Roberfroid, M., 1987, Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment, Int. J. Cancer 40: 575–579.CrossRefGoogle Scholar
  383. Tekenaga, K., Honma, Y., and Hozumi, M., 1981, Inhibition of differentiation of mouse myeloid leukemia cells by phenolic antioxidants and alpha-tocopherol, GANN 72: 104–112.Google Scholar
  384. Temcharoen, P., Anukarahanonta, T., and Bhamarapravati, N., 1978, Influence of dietary protein and vitamin B12 on the toxicity and carcinogenicity of aflatoxins in rat liver, Cancer Res. 38: 2185–2190.Google Scholar
  385. Teppo, L., and Saxén, E., 1979, Epidemiology of colon cancer in Scandinavia, Isr. J. Med. Sci. 15: 322–328.Google Scholar
  386. Thanassi, J. W., Nutter, L. M., Meisler, N. T., Commers, P., and Chiu, J-F., 1981, Vitamin B6 metabolism by Morris hepatomas, J. Biol. Chem. 256: 3370–3375.Google Scholar
  387. Thanassi, J. W., Meisler, N. T., and Kittler, J. M., 1985, Vitamin B6 metabolism and cancer, in: Vitamin B6: Its Role in Health and Disease ( J. E. Leklem, R. D. Reynolds, and E. E. McCoy, eds.), Alan R. Liss, New York, pp. 319–336.Google Scholar
  388. Thatcher, N., Blackledge, G., and Crowther, D., 1980, Advanced recurrent squamous cell carcinoma of the head and neck, Cancer 46: 1324–1328.CrossRefGoogle Scholar
  389. Thurnham, D. I., Rathakette, P., Hambridge, K. M., Munoz, N., and Crespi, M., 1982, Riboflavin, vitamin A and zinc status in Chinese subjects in a high-risk area for oesophageal cancer in China, Hum. Nutr. Clin. Nutr. 36C: 337–349.Google Scholar
  390. Toth, B., and Patil, K., 1983, Enhancing effect of vitamin E on murine intestinal tumorigenesis by 1,2dimethylhydrazine dihydrochloride, J. Natl. Cancer Inst. 70: 1107–1111.Google Scholar
  391. Trickier, D., and Shklar, G., 1987, Prevention by vitamin E of experimental oral carcinogenesis, J. Natl. Cancer Inst. 78: 165–169.Google Scholar
  392. Troll, W., Wiesner, R., and Frenkel, K., 1987, Anticarcinogenic action of protease inhibitors, Adv. Cancer Res. 49: 265–283.CrossRefGoogle Scholar
  393. Trown, P., Byck, M., and Hansen, R., 1976, Inhibition of growth and regression of a transplantable rat chrondrosarcoma by three retinoids, Cancer Treat. Rep. 60: 1647–1653.Google Scholar
  394. Tryfiates, G. P., and Morris, H. P., 1974, The effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four mouse hepatomas, J. Natl. Cancer Inst. 52: 1259–1262.Google Scholar
  395. Tryfiates, G. P., Bishop, R., and Smith, R. R., 1983, Identification of fatty acids associated with a novel tumor vitamin metabolite by GC-mass spectroscopy, J. Nutr. Growth Cancer 1: 1–9.Google Scholar
  396. Ura, H., Denda, A., Yokose, Y., Tsutsumi, M., and Konishi, Y., 1987, Effect of vitamin E on the induction and evolution of enzyme altered foci in the liver of rats treated with diethylnitrosamine, Carcinogenesis 8: 1595–1600.CrossRefGoogle Scholar
  397. van Eys, J., 1985, Nutrition and cancer, Annu. Rev. Nutr. 5: 435–461.CrossRefGoogle Scholar
  398. van Helden, P. D., Beyers, A. D., Bester, A. J., and Jaskiewicz, K., 1987, Esophageal cancer: Vitamin and lipotrope deficiencies in an at-risk South African population, Nutr. Cancer 10: 247–255.CrossRefGoogle Scholar
  399. Van Maanen, J. M., de Ruiter, C., de Vries, J., Koostra, P. R., Gobas, F., and Pinedo, H. M., 1985, The role of metabolic activation by cytochrome P-450 in covalent binding of VP 16–213 to rat liver and He La cell microsomal proteins, Eur. J. Cancer Clin. Oncol. 21: 1099–1106.CrossRefGoogle Scholar
  400. van Rensburg, S. J., 1981, Epidemiological and dietary evidence for a specific nutritional predisposition to esophageal cancer, J. Natl. Cancer Inst. 67: 243–251.Google Scholar
  401. van Tonder, S., Kew, M. C., Hodkinson, J., Metz, J., and Fernandez-Costa, F., 1985, Serum vitamin BI2 binders in South African blacks with hepatocellular carcinoma, Cancer 56: 789–792.CrossRefGoogle Scholar
  402. Van Vleet, V., and Ferrans, V., 1980, Evaluation of vitamin E and selenium protection against chronic adriamycin toxicity in rabbits, Cancer Treat. Rep. 64: 315–317.Google Scholar
  403. Wade, A. E., Greene, F. E., Ciordia, R. H., Meadows, J. S., and Caster, W. 0., 1969, Effect of dietary thiamin intake on hepatic drug metabolism in the rat, Biochem. Pharmacol. 18: 2288–2292.Google Scholar
  404. Wade, A. E., Wu, B. C., Holbrooke, C. M., and Caster, W. 0., 1973, Effects of thiamin antagonists on drug hydroxylation and properties of cytochrome P-450 in the rat, Biochem. Pharm. 22: 1573–1580.Google Scholar
  405. Wagner, C., 1985, Folate-binding proteins, Nutr. Rev. 43: 293–299.Google Scholar
  406. Wagner, C., Briggs, W. T., and Cook, R. J., 1985a, Inhibition of glycine N-methyltransferase activity by folate derivatives: Implications for regulation of methyl group metabolism, Biochem. Biophys. Res. Commun. 127: 746–752.CrossRefGoogle Scholar
  407. Wagner, D., Shuker, D. E. G., Blimazes, C., Obiedzinski, M., Baker, I., Young, V. R., and Tannenbaum, S. R., 1985b, Effects of vitamins C and E on endogenous synthesis of N-nitrosamino acids in humans: Presursor-product studies with [15N]nitrate, Cancer Res. 45: 6519–6522.Google Scholar
  408. Wald, N., Idle, M., and Boreham, J., 1980, Low serum vitamin A and subsequent risk of cancer, Lancet 2: 813–815.CrossRefGoogle Scholar
  409. Wald, N., Boreham, J., Hayward, J., and Bulbrook, R., 1984, Plasma retinol, beta-carotene, and vitamin E levels in relation to the future risk of breast cancer, Br. J. Cancer 49: 321–324.Google Scholar
  410. Wahrendorf, J., Munoz, N., Lu, J. B., Thurnham, D. I., Crespi, M., and Bosch, F. X., 1988, Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the esophagus: Findings from a vitamin intervention trial in the People’s Republic of China, Cancer Res. 48: 2280–2283.Google Scholar
  411. Wang, Y., Madanat, F., and Kimball, J., 1980, Effect of vitamin E against Adriamycin-induced toxicity in rabbits, Cancer Res. 40: 1022–1027.Google Scholar
  412. Wang, T., Miller, K. W., Tu, Y. Y., and Yang, C. S., 1985, Effects of riboflavin deficiency on metabolism of nitrosamines by rat liver microsomes, J. Natl. Cancer Inst. 74: 1291–1297.Google Scholar
  413. Ward, J., Sporn, M., Wenk, M., Smith, J., Feeser, D., and Dean, R., 1978, Dose response to intrarectal administration of N-methyl-N-Nitrosurea and histopatologic evaluation of the effect of two retinoids on colon lesions induced in rats, J. Natl. Cancer Inst. 60: 1489–1493.Google Scholar
  414. Wargovich, M. J., and Lointier, P. H., 1987, Calcium and vitamin D modulate mouse colon epithelial proliferation and growth characteristics of a human colon tumor cell line, Can. J. Physiol. Pharmacol. 65: 472–477.CrossRefGoogle Scholar
  415. Warrell, R., Coonley, C., and Itri, L., 1982, Clinical effects of 13-cis-retinoic acid in patients with lymphoid cancer, Clin. Res. 30: 692A.Google Scholar
  416. Warwick, G. P., and Harrington, J. S., 1973, Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on Transkei, South Africa, Adv. Cancer Res. 17: 81–229.CrossRefGoogle Scholar
  417. Wassertheil-Smoller, S., Romney, S. L., Wylie-Rosett, J., Slagle, G., Miller, D., Lucido, C., Duttagupta, P., and Palan, R., 1981, Dietary vitamin C and uterine cervical dysplasia, Am. J. Epiderm. 114: 714–724.Google Scholar
  418. Watson, R. R., 1986, Retinoids and vitamin E: Modulators of immune functions and cancer resistance, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 439–451.CrossRefGoogle Scholar
  419. Wattenberg, L., 1972, Inhibition of carcinogenic and toxic effects of polycyclic hydroxcarbons by phenolic antioxidants and ethoxyquin, J. Natl. Cancer Inst. 48: 1425–1430.Google Scholar
  420. Waxman, S., and Bruckner, H., 1982, The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione, and alpha-tocopherol, Eur. J. Can. Clin. Oncol. 18: 685–692.CrossRefGoogle Scholar
  421. Waxman, S., and Gilbert, H. S., 1973, A tumor-related vitamin B12-binding protein in adolescent hepatoma, N. Engl. J. Med. 289: 1053–1056.CrossRefGoogle Scholar
  422. Weber, T., Seitz, R. J., Liebert, U. G., Gallasch, E., and Wechsler, W., 1985, Affinity cytochemistry of vascular endothelia in brain tumors by biotinylated Ulex europaeus type I lectin (UEA I), Acta Neuropathol. 67: 128–135.CrossRefGoogle Scholar
  423. Welsch, C., Goodrich-Smith, M., Brown, C., and Crowe, N., 1981, Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice, J. Natl. Cancer Inst. 67: 935–938.Google Scholar
  424. Wenk, M., Ward, J., Resnik, G., and Dean, J., 1981, Effects of three retinoids on colon adenocarcinomas, sarcomas, and hyperplastic polyps induced by intrarectal N-methyl-N-nitrosurea administration in male F344 rats, Carcinogenesis 2: 1161–1166.CrossRefGoogle Scholar
  425. Werner, B., Hrynyschyn, K., and Schafer, H., 1985, Long-term study on vitamin C: No effect on experimental carcinogenesis, Langenbecks Arch. Chir. 363: 185–193.CrossRefGoogle Scholar
  426. Whelen, W., Walker, B., and Kelleher, J., 1983, Zinc, vitamin A and prostate cancer, Br. J. Urol. 55: 525–528.CrossRefGoogle Scholar
  427. White, H. B., III, and Merrill, A. H., Jr., 1988, Riboflavin-binding proteins, Annu. Rev. Nutr. 8: 279–299.CrossRefGoogle Scholar
  428. Whittaker, J., and Al-Ismail, S., 1983, Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukemia, Br. J. Med. 288: 283–284.CrossRefGoogle Scholar
  429. Willett, W. C., 1986, Selenium, vitamin E, fiber, and the incidence of human cancer: An epidemiologic perspective, Adv. Exp. Med. Biol. 206: 27–34.Google Scholar
  430. Willett, W., Polk, B., Underwood, B., Stampfer, M., Pressel, S., Rosner, B., Taylor, J., Schneider, K., and Hames, C., 1984, Relation of serum vitamins A and E and carotenoids to the risk of cancer, N. Engl. J. Med. 310: 430–434.CrossRefGoogle Scholar
  431. Wittes, R. E., 1985, Vitamin C and cancer, N. Engl. J. Med. 312: 178–179.CrossRefGoogle Scholar
  432. Wolbach, S., and Howe, P., 1925, Tissue changes following deprivation of fat-soluble A vitamin, J. Exp. Med. 42: 753–777.CrossRefGoogle Scholar
  433. Woolley, P. V., Kumar, S., Fitzgerald, P., and Simpson, R. T., 1987, Ascorbate potentiates DNA damage by 1- methyl-nitrosourea in vivo and generates DNA strand breaks in vitro, Carcinogenesis 8: 1657–1662.CrossRefGoogle Scholar
  434. Wynder, E. L., Hultberg, S., Jacobson, F., and Bross, I. J., 1957, Environmental factors in cancer of the upper alimentary tract. A Swedish study with special reference to Plummer—Vinson (Patterson—Kelly) syndrome, Cancer 10: 470–479.CrossRefGoogle Scholar
  435. Yamamoto, R. S., 1980, Effect of vitamin B12-deficiency in colon carcinogenesis, Proc. Soc. Exp. Biol. Med. 163: 350–353.CrossRefGoogle Scholar
  436. You, W. C., Blot, W. J., Chang, Y. S., Ershow, A. G., Yang, Z. T., An, Q., Henderson, B., Xu, G. W., Fraumeni, J. F., Jr., and Wang, T. G., 1988, Diet and high risk of stomach cancer in Shandong, China, Cancer Res. 48:3518–3523.Google Scholar
  437. Young, V. R., and Newberne, P. M., 1981, Vitamins and cancer prevention: Issues and dilemmas, Cancer 47 (Suppl. 5): 1226–1240.CrossRefGoogle Scholar
  438. Ziegler, I., Fink, M., and Wimanns, W., 1982, Biopterin levels in peripheral blood cells as a marker for hematopoietic cell proliferation during leukemia and polycythemia vera, Blut 44: 231–240.CrossRefGoogle Scholar
  439. Ziegler, R. G., 1986, Epidemiologic studies of vitamins and cancer of the lung, esophagus, and cervix, Adv. Exp. Med. Biol. 206: 11–26.Google Scholar
  440. Ziegler, R., Mason, T., Stemhagen, A., Hoover, R., Schoenberg, J., Gridley, G., Virgo, P., Altamn, R., and Fraumeni, J., Jr., 1984, Dietary carotene and vitamin A and risk of lung cancer among white men in New Jersey, J. Natl. Cancer Inst. 73: 1429–35.Google Scholar
  441. Ziegler, R. G., Mason, T. J., Sternhagen, A., Hoover, R., Schoenberg, J. B., Gridley, G., Virgo, P. W., and Fraumeni, J. F., Jr., 1986, Carotenoid intake, vegetables, and the risk of lung cancer among white men in New Jersey, Am. J. Epidemiol. 123: 1080–1093.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Alfred H. MerrillJr.
    • 1
  • Ann T. Foltz
    • 1
  • Donald B. McCormick
    • 1
  1. 1.Departments of Biochemistry and MedicineEmory University School of MedicineAtlantaUSA

Personalised recommendations